Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MTCR

Metacrine (MTCR) Stock Price, News & Analysis

Metacrine logo

About Metacrine Stock (NASDAQ:MTCR)

Advanced Chart

Key Stats

Today's Range
$0.58
$0.59
50-Day Range
$0.55
$0.59
52-Week Range
$0.30
$0.59
Volume
83,889 shs
Average Volume
225,834 shs
Market Capitalization
$24.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MTCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Metacrine and its competitors with MarketBeat's FREE daily newsletter.

MTCR Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

MTCR Stock Analysis - Frequently Asked Questions

Metacrine, Inc. (NASDAQ:MTCR) announced its earnings results on Thursday, May, 13th. The company reported ($0.57) earnings per share for the quarter, missing the consensus estimate of ($0.51) by $0.06.

Metacrine (MTCR) raised $84 million in an initial public offering (IPO) on Wednesday, September 16th 2020. The company issued 6,500,000 shares at $12.00-$14.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and Canaccord Genuity was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Metacrine investors own include Oncobiologics (OTLK), Plug Power (PLUG), Advanced Micro Devices (AMD), Salesforce (CRM), Fisker (FSR), Micron Technology (MU) and 9 Meters Biopharma (NMTR).

Company Calendar

Last Earnings
5/13/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MTCR
CIK
1634379
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.21 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-84.88%
Return on Assets
-59.33%

Debt

Debt-to-Equity Ratio
0.34
Current Ratio
12.15
Quick Ratio
12.15

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.36 per share
Price / Book
0.43

Miscellaneous

Outstanding Shares
42,570,000
Free Float
36,695,000
Market Cap
$24.75 million
Optionable
Not Optionable
Beta
-0.73
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:MTCR) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners